CVS Health Corporation (CVS) analyst actions
Rating and price-target actions on CVS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CVS overview →
1 measured CVS analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Omnicare Initiates Voluntary Chapter 11 Process | Press release | +0.09% | +0.13% |
Keep exploring
More CVS: earnings → · SEC filings → · CVS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GENOMIC HEALTH (GHDX) | 1,111 | 0.00% | 49% |
| INDIVIOR PLC S/ADR (INVVY) | 1,105 | 0.00% | 33% |
| Idera Pharmaceuticals, Inc. (IDRA) | 1,094 | -0.27% | 42% |
| Soleno Therapeutics, Inc. (SLNO) | 1,089 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.